---
title: "Corvus制药 (CRVS.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CRVS.US/norm.md"
symbol: "CRVS.US"
name: "Corvus制药"
parent: "https://longbridge.com/zh-CN/quote/CRVS.US.md"
datetime: "2026-05-19T18:49:35.323Z"
locales:
  - [en](https://longbridge.com/en/quote/CRVS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRVS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRVS.US/norm.md)
---

# Corvus制药 (CRVS.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1521 | -0.1485 | -0.1226 | -0.1028 | -0.1322 |
| ROE | -36.28% | -74.13% | -53.46% | -49.39% | 148.42% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -13.69M | -12.32M | -10.16M | -8.00M | 15.19M |
| 营业利润 | -14.88M | -12.22M | -10.57M | -10.26M | -9.92M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 253.19M | 71.12M | 80.47M | 89.46M | 59.44M |
| 权益乘数 | 1.05 | 1.16 | 1.12 | 1.12 | 1.21 |
| 每股净资产 | 2.86 | 0.8194 | 0.9610 | 1.08 | 0.7236 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 236.71M | 56.75M | 65.69M | 74.41M | 44.21M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 1.03M | 1.06M | 1.15M | 1.26M | 1.26M |
| 净债务 | -235.88M | -55.81M | -64.68M | -73.32M | -43.06M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -10.37M | -9.19M | -9.57M | -5.78M | -8.26M |
| 投资现金流 | -144.85M | 10.88M | -2.62M | -20.30M | 4.24M |
| 融资现金流 | 190.75M | 20000.00 | 360000.00 | 35.77M | 279000.00 |
| 自由现金流 | -5.77M | -4.99M | -5.67M | -6.14M | -30.06M |
| 现金流充裕率 | -11400.00% | -36764.00% | - | -5112.39% | -22952.78% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -91000.00 | -25000.00 | 0.0000 | -113000.00 | -36000.00 |